In addition to data within paper and supporting information, expression data are uploaded to the NCBI GEO database (accession number: GSE78889).

Introduction {#sec005}
============

Mucopolysaccharidosis type I (MPS I), caused by a deficiency of the lysosomal enzyme α-L-iduronidase (IDUA), results in shortened lifespan, multisystemic somatic involvement, and variable neurocognitive degeneration because of accumulation of heparan sulfate (HS) and dermatan sulfate (DS) glycosaminoglycan (GAG) substrates in body tissues such as brain, soft tissues, chondrocytes, liver, and spleen \[[@pone.0150850.ref001]\]. Cardiovascular disease is a cardinal manifestation of MPS I, characterized by progressive thickening and compromised function of the heart valves, left ventricular hypertrophy, and diffuse coronary artery stenosis \[[@pone.0150850.ref002]--[@pone.0150850.ref006]\].

The advent of treatments to replace the missing IDUA enzyme, whether with intravenous enzyme replacement therapy (ERT) or via hematopoietic stem cell transplant (HSCT), has enabled MPS I patients to survive into adulthood \[[@pone.0150850.ref007], [@pone.0150850.ref008]\]. Although ERT and HSCT are able to mitigate many symptoms of MPS I, clinical experience has demonstrated that these treatments attenuate, but do not cure, the disease. Certain tissues remain resistant to treatment and continue to manifest GAG storage. Consequently, as MPS I patients survive into adulthood they face a different set of potentially life-threatening disease complications such as those involving the cardiovascular system \[[@pone.0150850.ref009], [@pone.0150850.ref010]\]. Cardiac sudden death, left-sided valvular insufficiency, ventricular dysfunction, and coronary intimal proliferation with stenosis all have been reported in stably treated patients \[[@pone.0150850.ref011]--[@pone.0150850.ref014]\]. Accumulation of GAG within cardiovascular structures in the face of ongoing treatment is the likely origin of these symptoms, as well as childhood-onset carotid intima-media thickening and abnormally reduced elasticity \[[@pone.0150850.ref015]--[@pone.0150850.ref019]\].

The pathogenesis and etiologies of treatment resistance of cardiovascular disease in MPS I are not well characterized, but studies in the murine and canine models of the disease indicate that accumulation of undegraded HS and DS GAG in the heart, valves, and vasculature alone do not adequately describe the pathophysiology. Both untreated and treated MPS I canines develop similar cardiovascular findings to human MPS I, with cardiac hypertrophy, nodular valve thickening, and vascular smooth muscle proliferation of the aorta with luminal stenosis \[[@pone.0150850.ref020]--[@pone.0150850.ref022]\]. Detailed histopathology of canine aortic lesions demonstrates vascular smooth muscle proliferation, activated CD68^+^ macrophages, and fragmented elastin fibrils in addition to GAG storage \[[@pone.0150850.ref023]\]. The murine MPS I model also manifests with cardiac enlargement, valvular thickening and dysfunction, and dilatation of the aorta with vascular wall thickening with elastin fibril degradation \[[@pone.0150850.ref024], [@pone.0150850.ref025]\].

Gene expression studies are a useful method to identify potential mechanisms of disease progression, but have not been comprehensively assessed for cardiovascular disease in any model of MPS I. The primary focus of expression studies for the mucopolysaccharidoses has been neurodegeneration in the Sanfilippo syndromes (MPS III) and Sly syndrome (MPS VII) \[[@pone.0150850.ref026]--[@pone.0150850.ref030]\]. Assessment of aortic mRNA expression for dogs with MPS I and VII, and mice with MPS VII has centered on quantification of cytokine, complement, and other inflammation-related genes \[[@pone.0150850.ref031]--[@pone.0150850.ref034]\]. Herein, we report alterations in arterial gene and protein expression in the canine MPS I model system, the identification of a potential marker for MPS I cardiovascular disease, and data supporting the hypothesis that a GAG-induced inflammatory process is responsible for the pathogenesis of MPS I cardiovascular disease.

Materials and Methods {#sec006}
=====================

Test animals and husbandry {#sec007}
--------------------------

This study was reviewed and approved by the Institutional Animal Care and Use Committees of both Iowa State University (IACUC \#12-04-5791-K) and the Los Angeles Biomedical Research Institute at Harbor-UCLA (LA BioMed IACUC \#20013--01). Studies were conducted in compliance with both UDSA and NIH guidelines for the use of dogs in research. Four MPS I (IDUA^-/-^) canines were produced from artificial insemination breedings of parental stock, diagnosed via α-L-iduronidase enzyme assay and PCR, and maintained at Iowa State University until 1 year of age, after which they were transported to LA BioMed, an AAALAC accredited facility overseen by a licensed veterinarian. Animals had *ad libitum* access to food (standard Teklad canine lab chow) and water, housing with enrichment, and a 12 hour light/dark cycle. Housing consisted of expanded mesh flooring, and involved housing with compatible conspecifics as required for social species unless medically or behaviorally contraindicated. Animal care was provided by the Laboratory Animal Resources veterinary staff of the respective institutions. The dog colony has a null mutation in intron 1 of the canine α-L-iduronidase gene that results in abnormal mRNA splicing, introduces a premature termination codon, and completely eliminates IDUA protein expression \[[@pone.0150850.ref035]\]. The four dogs were neither tolerized nor treated with IV rhIDUA, and had received six monthly intra-articular rhIDUA injections as previously reported \[[@pone.0150850.ref036]\].

Mouse-related protocols were approved by the University of California San Diego IACUC Animal Subjects Committee (IACUC \#S99127). The MPS I (*Idua*^-/-^) mouse colony was housed, maintained, and veterinarian-supervised at The University of California San Diego, an AAALAC accredited facility. The colony, which is on the C57BL/6 background, was originally obtained from the Jackson Laboratories (B6.129-Idua^tm1Clk/J^) and was bred locally for 9 generations. *Idua* genotyping was performed as per [S1 Appendix](#pone.0150850.s001){ref-type="supplementary-material"}. Mice utilized for this study were fed standard chow and were neither tolerized nor treated with any form of rhIDUA.

Tissue collection and euthanasia {#sec008}
--------------------------------

At 18 months of age, dogs were euthanized with a 1 cc / 10 lb dose of euthasol and 1 cm rings from the ascending aorta, descending aorta proximal to the renal arteries, and common carotid arteries were immediately obtained post-mortem. Arterial rings were processed as follows: 1) one section from each site was embedded in a cryomold with OCT (Tissue-Tek CRYO-OCT Compound, ThermoFisher Scientific, Waltham, MA), frozen and stored at -80°C, 2) one section placed in TRIzol solution (Life Technologies, Grand Island, NY) for subsequent RNA extraction, 3) and one section frozen and stored at -80°C for subsequent Western blotting.

At 9--12 months of age, female MPS I (mean age, 9.4 months; n = 8) and age-matched wild-type (mean age, 10.2 months n = 3) mice were euthanized with a combination of Isoflurane inhalation (Abbott, North Chicago, IL), cervical dislocation, and exsanguination. Heart and aorta collection was performed as per Daugherty and Whitman, and summarized as follows: after exsanguination, the right atrium was incised and the animal was perfused with 20 mL cold phosphate buffered saline (PBS) through the left ventricle \[[@pone.0150850.ref037]\]. The abdominal viscera were removed and the heart and aorta were carefully dissected *en bloc* to the iliac bifurcation. The heart was cut from the ascending aorta approximately 5 mm from the point of emergence from the left ventricle, embedded in a cryomold with OCT, and stored frozen at -80°C.

RNA isolation, amplification, and labeling {#sec009}
------------------------------------------

RNA isolation from canine aortic specimens was performed using the TRIzol RNA Purification System (Life Technologies, Grand Island, NY). RNA concentration and quality, as well as dye incorporation efficiency, was checked with an ND-1000 spectrophotometer (NanoDrop Technologies, Rockland, DE, USA) and the Agilent Bioanalyzer 2100. A total of 100 ng RNA was used as initial starting template, which was labeled with Cy-3 or Cy-5 cytidine 5'-triphosphate using the low input fluorescent linear amplification kit (Agilent, Santa Clara, CA).

Microarray hybridizations and data analysis {#sec010}
-------------------------------------------

Comparisons of canine arterial gene expression between control and untreated MPS animals were conducted with a canine-specific microarray covering 43,803 probes (Agilent G2519F 4x44k, Santa Clara, CA), for a total of four comparison groups: MPS ascending aorta vs. control ascending aorta, MPS descending aorta vs. control descending aorta, MPS carotid artery vs. control carotid artery, and finally pooled MPS artery (ascending aorta, descending aorta, carotid artery) vs. pooled control artery. Each comparison used four pairs of MPS vs corresponding age- and gender- matched animals to produce four biologic replicates.

Bioinformatic analysis {#sec011}
----------------------

The data was analyzed by the WGCNA package in R 3.0.2, a package we have used previously to analyze large datasets and identify novel genomic targets \[[@pone.0150850.ref038]--[@pone.0150850.ref041]\]. Co-expression networks were formed on genes with similar behavior. Trait information (e.g. ascending aorta, carotid artery, and descending aorta) and Pearson correlation data were obtained.

Database for Annotation, Visualization and Integrated Discovery (DAVID) v6.7 was used to functionally annotate the genes that clustered together \[[@pone.0150850.ref042],[@pone.0150850.ref043]\]. DAVID's functional annotation tool allows for pathway analysis using the Kyoto Encyclopedia of Genes and Genomes (KEGG), gene ontology annotation for biological processes, molecular function, and cellular components, assessment of transcription factor binding sites, and identification of tissues matching the gene clusters. All relationships determined had corresponding statistics within DAVID. The functional annotations presented here had a p-value ≤ 0.05 with Bonferroni correction.

Network analysis was performed using two methods. The first was WGCNA to identify networks without any prior knowledge. This enabled discovery of novel nodes and edges that could be visualized using Cytoscape version 3.1.1 \[[@pone.0150850.ref044]\]. The second was with GeneMania (a plugin available in Cytoscape) to examine connections based on prior evidence including co-expression, shared protein domains, pathway, physical interactions, genetic interactions, and co-localization \[[@pone.0150850.ref039], [@pone.0150850.ref045]\].

Western blotting {#sec012}
----------------

Flash frozen sections of harvested ascending and descending aorta that had been harvested from homozygous MPS I and heterozygous carrier dogs and stored at -80°C were thawed on ice. Sections of approximately 30 to 50 mg of each tissue sample were cut and mixed in a 1:3 weight to volume ratio with lysis buffer containing 4% SDS, EDTA, a protease inhibitor cocktail (P8340, Sigma-Aldrich, St. Louis, MO) and phosphatase inhibitor cocktails (P0044 and P5726, Sigma-Aldrich, St. Louis, MO). Standard Dounce homogenization was performed while each tissue sample was kept on ice in a 4°C room. After homogenization, each sample was sonicated in a 4°C water bath for 1 hour and then centrifuged at 10,000 rpm for 10 minutes. The supernatant was collected and centrifuged again at 10,000 rpm for 10 minutes. This supernatant was collected and total protein content of each sample was determined with a standard colorimetric assay (Bio-Rad, Philadelphia, PA) converting absorbance measured as optical density units at 595 nm (Shimadzu BioSpec 1601 Double Beam UV-Visible Spectrophotometer, Shimadzu Scientific Instruments, Columbia, MD) to protein concentration using bovine serum albumin as a standard.

Samples were diluted to a final concentration of 4 μg/μL by addition of the appropriate volume of a standard Laemmli loading buffer. These were then heated to 95°C for 20 minutes prior to loading onto a gel (Novex Tris-Glycine 4--20% Mini Protein Gel, Life Technologies, Grand Island, NY). Each well was loaded with 20 μg of total protein and a protein ladder covering the size range from 10 to 180 kDa (PageRuler Prestained Protein Ladder, Life Technologies, Grand Island, NY) was loaded in one well of each gel for reference. Separation was performed via 4--20% Tris-Glycine SDS-PAGE followed by transfer to a nitrocellulose membrane (BioTrace NT nitrocellulose transfer membrane, Pall Corp., Port Washington, NY).

Standard immunoblotting was then performed with mouse monoclonal anti-human clusterin alpha chain (1:1,000 or 1 ng/μL; EMD Millipore, Billerica, MA) diluted in 2.5% nonfat milk and incubated overnight at 4°C. After washing, the membrane was incubated for one hour at room temperature with goat anti-mouse IgG HRP conjugated secondary antibody (1:50,000; Southern Biotechnology, Birmingham, AL, USA) diluted in 2.5% nonfat milk, and then detected with Immobilon Chemiluminescent HRP Substrate (EMD Millipore, Billerica, MA). Membranes were then stripped, washed and re-probed with mouse monoclonal anti-human smooth muscle alpha-actin (1:10,000; Dako North America, Inc., Carpinteria, CA) diluted in 2.5% nonfat milk. After washing, the membrane was incubated for one hour at room temperature with goat anti-mouse IgG HRP conjugated secondary antibody (1:100,000; Southern Biotechnology, Birmingham, AL) diluted in 2.5% nonfat milk, and then detected with Immobilon Chemiluminescent HRP Substrate (EMD Millipore, Billerica, MA).

Western blot band intensities were quantified using ImageJ. After conversion of Western blot images to black and white and subtraction of background, the signal intensities of clusterin bands were subsequently measured and normalized to signal intensities of corresponding α-actin bands. The ratio of mean normalized MPS I clusterin intensity to mean heterozygote clusterin intensity was calculated to determine fold-change expression in ascending and descending aorta homogenates.

Canine aorta immunohistochemistry {#sec013}
---------------------------------

Transverse cuts through each OCT-embedded tissue sample were taken with a cryostat at -20°C to produce 12 micron-thick cross-sectional slices that were mounted on glass slides. Slide mounted tissue sections were covered with neutral PBS at room temperature for twenty minutes, rinsed, and then fixed with 4% paraformaldehyde in PBS for 20 minutes. Slides were washed in PBS and then each tissue section was blocked with hydrogen peroxide for 20 minutes. After washing in PBS each tissue section was then blocked with 5% normal goat serum in PBS for one hour at room temperature. Tissue sections were then incubated overnight at 4°C with mouse monoclonal anti-human clusterin alpha chain antibody (1:2,500 or 0.4 ng/μl; EMD Millipore, Billerica, MA) diluted in 3% BSA in neutral PBS, mouse monoclonal anti-human smooth muscle alpha actin antibody (1:2,500; Dako North America, Inc., Carpinteria, CA) diluted in 3% BSA in neutral PBS, or 3% BSA in neutral PBS alone. Detection of specific staining was performed with an anti-mouse HRP-conjugated secondary antibody and diaminobenzidine (DAB) substrate-chromogen (EXPOSE Mouse and Rabbit HRP/DAB Detection Kit, Abcam, Cambridge, MA) according to manufacturer's protocol. Tissue sections were counterstained with hematoxylin prior to visualization. Cover slips were applied to each slide and standard bright field optical microscopy was performed. In the transverse aorta sections positive (DAB) signal appears brown while the counterstain appears blue.

Murine aorta preparation and immunohistochemistry {#sec014}
-------------------------------------------------

6 micron-thick cross-sections of heart and aorta were obtained from OCT-embedded samples with a cryostat at -20°C, mounted on glass slides, dried at room temperature for 30 minutes and then fixed in fresh 10% neutral buffered formalin (Fisher \#SF94-4, Waltham, MA) for 15 minutes. Slides were washed 3 times in PBS with Tween-20® (PBST). Endogenous peroxidases were blocked with a 0.03% solution of hydrogen peroxide in PBST, then washed another 3 times in PBST. Slides were overlaid with 1% BSA in PBST (Sigma \#A4503, St Louis, MO) for 10 minutes, endogenous biotin blocked with Vector Labs \#SP-2001 kit, and washed another 3 times in PBST. Slides were then overlaid with 1% BSA in PBST and polyclonal goat anti-mouse clusterin alpha chain (1:100; Santa Cruz \#SC-6420, Dallas, TX), incubated at room temperature for 1 hour, and washed 3 times in PBST. Secondary staining was accomplished with biotinylated donkey anti-goat antibody (1:500; Jackson ImmunoResearch Laboratories \#805-065-180, West Grove, PA) incubated 30 minutes at room temperature, then washed 3 times in PBST. Slides were then incubated with streptavidin-HRP (1:500; Jackson ImmunoResearch Laboratories \#016-030-084, West Grove, PA) for 30 minutes, rinsed, then developed with 3-amino-9-ethylcarbazole chromogen (Vector Labs \#SK-4200, Burlingame, CA) for 10 minutes. Slides were counterstained in Mayer's Hematoxylin (Sigma \#MHS16, St Louis, MO) for 1 minute, washed in PBST, air dried, and cover slips applied with aqueous mounting media (Vector Labs \#H-5501, Burlingame, CA).

Results {#sec015}
=======

Microarray was performed on IDUA^-/-^ and control (IDUA^+/-^) canine arterial samples obtained from common carotid artery, ascending aorta, and descending aorta. Data was initially analyzed using principal component analysis (PCA). Two clusters were visualized, clearly differentiating the IDUA^-/-^ arterial expression patterns from the control patterns ([Fig 1A](#pone.0150850.g001){ref-type="fig"}). Dendrograms and trait heatmaps were also made using the adjacency matrix technique ([S1 Fig](#pone.0150850.s002){ref-type="supplementary-material"}). Using both of these dimension reduction methods, it can easily be determined if the samples cluster together or if there are outliers. Again, two main clusters were observed, one for IDUA^-/-^ and the other for control. In addition, expression patterns from different animals at the same arterial sites demonstrated clustering according to IDUA genotype. In other words, carotid artery expression in the MPS I animals clustered together and was distinct from both MPS I ascending aorta expression and descending aorta expression patterns.

![Microarray Results From IDUA^-/-^ Canine Arterial Samples.\
A. Principal component analysis of IDUA^-/-^ canine arteries compared to control canine arteries clearly shows the formation of two sample clusters separating IDUA^-/-^ and control expression. B. WGCNA dendrogram on the microarray samples showing different modules related to the Pearson correlation of the IDUA^-/-^ and control samples. C. Heatmaps of the two major modules (turquoise and blue) formed by WGCNA showing genes upregulated (top panel) or downregulated (bottom panel) by IDUA deficiency. D. Genes significantly upregulated in IDUA^-/-^ canine arteries include those related to immunity / inflammation (KEGG pathways: antigen processing and presentation, graft-versus-host disease), proteasomal function, and lysosomal function. E. Genes significantly downregulated in IDUA^-/-^ canine arteries are primarily related to cellular adhesion and the cytoskeleton (placed into the dilated cardiomyopathy, focal adhesion, arrhythmogenic right ventricular cardiomyopathy KEGG pathways).](pone.0150850.g001){#pone.0150850.g001}

Data was subsequently analyzed using whole genome correlation network analysis (WGCNA) to identify specific modules that related back to the MPS I trait. Use of this method loosens the stringency in the analysis, since groups of genes are examined together allows a significance matrix to be made based on the networks formed \[[@pone.0150850.ref046]\]. Genes were further categorized based on fold-change and additional statistical tests within each module. The lists of probes/genes 2-fold or more upregulated or downregulated compared to control across modules can be found in Tables [1](#pone.0150850.t001){ref-type="table"} and [2](#pone.0150850.t002){ref-type="table"}, respectively; full listings are included in [S1](#pone.0150850.s007){ref-type="supplementary-material"} and [S2](#pone.0150850.s008){ref-type="supplementary-material"} Tables. Subsequently, a dendrogram was made to represent the modules formed with the Pearson correlations for each trait shown ([Fig 1B](#pone.0150850.g001){ref-type="fig"}). There were ten total modules that formed ([S2 Fig](#pone.0150850.s003){ref-type="supplementary-material"}). Specific attention was paid to the turquoise and blue modules because those were the most statistically significant modules representing genes consistently upregulated in all three sampled vascular segments of the IDUA^-/-^ dogs (upper panel, [Fig 1C](#pone.0150850.g001){ref-type="fig"}), or genes consistently downregulated in all three sampled vascular segments of the IDUA^-/-^ dogs (lower panel, [Fig 1C](#pone.0150850.g001){ref-type="fig"}). Further downstream analysis with a volcano plot to identify the top targets within the turquoise and blue modules is seen in [S3 Fig](#pone.0150850.s004){ref-type="supplementary-material"}.

10.1371/journal.pone.0150850.t001

###### Upregulated Genes in IDUA^-/-^ Canine Arteries.

The 50 upregulated genes with significant (p-value ≤ 0.05) and greater than 2-fold level of upregulation in IDUA^-/-^ canine arteries, compared to controls. Note that some genes are represented more than once due to existence of multiple mRNA probes per gene. For the full list of significantly upregulated genes, please refer to [S1 Table](#pone.0150850.s007){ref-type="supplementary-material"}.

![](pone.0150850.t001){#pone.0150850.t001g}

  Fold Change   Gene Symbol          Systematic Name      Description
  ------------- -------------------- -------------------- ---------------------------------------------------------------------------------------------------------------------------------------------------
  27.126        GPNMB                XM_858105            PREDICTED: Canis familiaris similar to glycoprotein (transmembrane) nmb isoform b precursor, transcript variant 3 (LOC482355), mRNA \[XM_858105\]
  20.245        GPNMB                XM_858105            PREDICTED: Canis familiaris similar to glycoprotein (transmembrane) nmb isoform b precursor, transcript variant 3 (LOC482355), mRNA \[XM_858105\]
  12.432        ENSCAFT00000039657   ENSCAFT00000039657   Osteopontin (Fragment)
  11.926        CSTB                 XM_535601            PREDICTED: Canis familiaris similar to Cystatin B
  11.566        ENSCAFT00000039661   ENSCAFT00000039661   Osteopontin (Fragment)
  10.506        DLA-DRA1             ENSCAFT00000001254   MHC class II DR alpha chain
  10.220        CLU                  NM_001003370         Canis lupus familiaris clusterin (CLU)
  9.595         CLU                  NM_001003370         Canis lupus familiaris clusterin (CLU)
  9.464         CTSK                 ENSCAFT00000035613   Cathepsin K precursor
  8.985         TC71707              TC71707              Q49RE5_CANFA (Q49RE5) Cytochrome b, partial (35%)
  7.766         CSTB                 XM_535601            PREDICTED: Canis familiaris similar to Cystatin B
  7.587         LOC479746            XM_536874            PREDICTED: Canis familiaris similar to Ferritin light chain 2
  7.022         TC57368              TC57368              HUMLPLSTN2 L-plastin {Homo sapiens}
  6.975         GPNMB                XM_858105            PREDICTED: Canis familiaris similar to glycoprotein (transmembrane) nmb isoform b precursor, transcript variant 3 (LOC482355), mRNA \[XM_858105\]
  6.968         CLU                  NM_001003370         Canis lupus familiaris clusterin (CLU)
  6.947         CD86                 NM_001003146         Canis lupus familiaris CD86 molecule (CD86)
  6.769         DR104862             DR104862             Canine cardiovascular system biased cDNA
  6.738         FTL                  NM_001024636         Canis lupus familiaris ferritin, light polypeptide
  6.718         CTSS                 NM_001002938         Canis lupus familiaris cathepsin S (CTSS)
  6.704         CLU                  NM_001003370         Canis lupus familiaris clusterin (CLU)
  6.677         APOE                 XM_847504            PREDICTED: Canis familiaris apolipoprotein E, transcript variant 2 (APOE)
  6.666         CTSK                 NM_001033996         Canis lupus familiaris cathepsin K (CTSK)
  6.655         CTSK                 NM_001033996         Canis lupus familiaris cathepsin K (CTSK)
  6.605         LGMN                 XM_537355            PREDICTED: Canis familiaris similar to Legumain precursor
  6.453         CTSK                 NM_001033996         Canis lupus familiaris cathepsin K (CTSK)
  6.423         DLA-DRB1             NM_001014768         Canis lupus familiaris MHC class II DLA DRB1 beta chain (DLA-DRB1)
  6.193         FTL                  NM_001024636         Canis lupus familiaris ferritin, light polypeptide (FTL)
  6.178         CTSK                 NM_001033996         Canis lupus familiaris cathepsin K (CTSK)
  6.055         TYRP1                XM_859450            PREDICTED: Canis familiaris tyrosinase-related protein 1 (TYRP1)
  6.026         CTSK                 NM_001033996         Canis lupus familiaris cathepsin K (CTSK)
  6.013         BPI                  XM_534417            PREDICTED: Canis familiaris similar to Bactericidal permeability-increasing protein precursor (BPI)
  6.006         CTSB                 XM_543203            PREDICTED: Canis familiaris similar to cathepsin B preproprotein
  5.833         TC50899              TC50899              Q9N2I5_FELCA (Q9N2I5) CD16
  5.828         TC62836              TC62836              FCU92795 fusin {Felis catus}
  5.727         LGMN                 XM_537355            PREDICTED: Canis familiaris similar to Legumain precursor
  5.680         DLA-DQB1             NM_001014381         Canis lupus familiaris MHC class II, DQ beta 1 (DLA-DQB1)
  5.660         CSGALNACT1           XM_539946            PREDICTED: Canis familiaris similar to chondroitin beta1,4 N-acetylgalactosaminyltransferase
  5.651         MT2A                 NM_001003149         Canis lupus familiaris metallothionein 2A (MT2A)
  5.493         TC51307              TC51307              Unknown
  5.331         TGM2                 XM_542991            PREDICTED: Canis familiaris similar to Protein-glutamine gamma-glutamyltransferase
  5.306         SMOC2                XM_858080            PREDICTED: Canis familiaris similar to secreted modular calcium-binding protein 2
  5.190         ASAH1                XM_540012            PREDICTED: Canis familiaris similar to N-acylsphingosine amidohydrolase (acid ceramidase)
  5.152         APOE                 ENSCAFT00000007432   Apolipoprotein E (Apo-E)
  5.104         TC54889              TC54889              Unknown
  5.069         DLA-DRA1             NM_001011723         Canis lupus familiaris MHC class II DR alpha chain (DLA-DRA1)
  4.984         RRAGD                XM_532231            PREDICTED: Canis familiaris similar to Ras-related GTP binding D
  4.921         E02824               E02824               Canis familiaris cDNA clone LIB30321_005_G04
  4.912         RRAGD                XM_532231            PREDICTED: Canis familiaris similar to Ras-related GTP binding D
  4.902         TYROBP               XM_533687            PREDICTED: Canis familiaris similar to TYRO protein tyrosine kinase binding protein isoform 2 precursor
  4.882         FTH1                 ENSCAFT00000025200   Ferritin heavy chain (EC 1.16.3.1) (Ferritin H subunit)

10.1371/journal.pone.0150850.t002

###### Down-regulated Genes in IDUA^-/-^ Canine Arteries.

The 50 down-regulated genes with significant (p-value ≤ 0.05) and greater than 2-fold level of down-regulation in IDUA^-/-^ canine arteries, compared to controls. Again, some genes are represented more than once due to existence of multiple mRNA probes per gene. For the full list of significantly down-regulated genes, please refer to [S2 Table](#pone.0150850.s008){ref-type="supplementary-material"}.

![](pone.0150850.t002){#pone.0150850.t002g}

  Fold Change   Gene Symbol          Systematic Name      Description
  ------------- -------------------- -------------------- ------------------------------------------------------------------------------------------------------------------------------
  4.948         TC67209              TC67209              HUMRPS17A S17 ribosomal protein {Homo sapiens}
  3.970         LRRK2                XM_543734            PREDICTED: Canis familiaris similar to leucine-rich repeat kinase 2
  3.666         CNN1                 XM_862565            PREDICTED: Canis familiaris similar to calponin 1, basic, smooth muscle, transcript variant 4
  3.392         CO611926             CO611926             DG9-109j22 DG9-ovary Canis familiaris cDNA 3\'
  3.309         SMTN                 XM_860837            PREDICTED: Canis familiaris similar to smoothelin isoform c
  3.218         NRGN                 XM_536537            PREDICTED: Canis familiaris similar to neurogranin (LOC479401)
  3.212         CSRP1                XM_843516            PREDICTED: Canis familiaris similar to Cysteine and glycine-rich protein 1
  3.157         TCAP                 XM_858636            PREDICTED: Canis familiaris similar to Telethonin (Titin cap protein)
  3.109         PPP1R12B             XM_843384            PREDICTED: Canis familiaris similar to Protein phosphatase 1 regulatory subunit 12B (Myosin phosphatase targeting subunit 2)
  3.018         DN756599             DN756599             GL-Cf-13395 GLGC-LIB0001-cf Canis familiaris Normalized Mixed Tissue cDNA
  2.949         LOC488984            XM_843847            PREDICTED: Canis familiaris similar to Actin, alpha skeletal muscle
  2.865         AB012223             AB012223             Canis familiaris LINE-1 element ORF2 mRNA
  2.855         ENSCAFT00000034839   ENSCAFT00000034839   NADH-ubiquinone oxidoreductase chain 3
  2.836         PPP1R12B             XM_843384            PREDICTED: Canis familiaris similar to Protein phosphatase 1 regulatory subunit 12B (Myosin phosphatase targeting subunit 2)
  2.812         ENSCAFT00000034824   ENSCAFT00000034824   NADH-ubiquinone oxidoreductase chain 2 (EC 1.6.5.3) (NADH dehydrogenase subunit 2)
  2.812         BM538907             BM538907             hb02c06.g1 Canis cDNA from testes cells Canis familiaris cDNA clone
  2.782         LOC488984            XM_843847            PREDICTED: Canis familiaris similar to Actin, alpha skeletal muscle
  2.764         TC55776              TC55776              Unknown
  2.761         TAGLN                XM_856022            PREDICTED: Canis familiaris similar to transgelin, transcript variant 3
  2.734         FHL1                 XM_549282            PREDICTED: Canis familiaris similar to four and a half LIM domains 1
  2.712         LOC488984            XM_843847            PREDICTED: Canis familiaris similar to Actin, alpha skeletal muscle
  2.705         OGN                  XM_848247            PREDICTED: Canis familiaris similar to Mimecan precursor (Osteoglycin)
  2.692         DMD                  NM_001003343         Canis lupus familiaris dystrophin (muscular dystrophy, Duchenne and Becker types)
  2.673         TC68286              TC68286              Unknown
  2.630         ENSCAFT00000022802   ENSCAFT00000022802   Fibronectin (FN) (Fragment)
  2.626         SLC22A3              XM_533467            PREDICTED: Canis familiaris similar to solute carrier family 22 member 3
  2.617         LOC488984            XM_843847            PREDICTED: Canis familiaris similar to Actin, alpha skeletal muscle
  2.598         DN879822             DN879822             nae29h08.y1 Dog eye eye minus lens and cornea. Unnormalized (nae)
  2.594         PTGS1                NM_001003023         Canis lupus familiaris prostaglandin-endoperoxide synthase 1
  2.586         LOC491592            XM_548713            PREDICTED: Canis familiaris similar to ankyrin repeat domain 26
  2.567         PPAP2B               XM_536696            PREDICTED: Canis familiaris similar to phosphatidic acid phosphatase type 2B
  2.526         PPAP2B               XM_536696            PREDICTED: Canis familiaris similar to phosphatidic acid phosphatase type 2B
  2.489         C1QTNF1              XM_843609            PREDICTED: Canis familiaris similar to C1q and tumor necrosis factor related protein 1
  2.481         TPM1                 ENSCAFT00000026876   Tropomyosin (Fragment)
  2.460         MYH11                XM_857511            PREDICTED: Canis familiaris similar to smooth muscle myosin heavy chain 11 isoform SM1
  2.459         ADCY5                M88649               Canis familiaris adenylyl cyclase type V
  2.458         LOC480803            XM_537918            PREDICTED: Canis familiaris similar to ankyrin repeat domain 26
  2.429         TC48376              TC48376              MALAT_HUMAN (Q9UHZ2) Metastasis-associated lung adenocarcinoma transcript 1
  2.407         CF412534             CF412534             Canine heart normalized cDNA Library, pBluescript Canis familiaris cDNA clone CH3\#080_C09 5\'
  2.405         DN368051             DN368051             LIB3731-002-Q6-K7-H5 LIB3731 Canis familiaris cDNA clone CLN2470649
  2.393         CN005552             CN005552             ip32c07.g1 Brain---Cerebellum Library (DOGEST8) Canis familiaris cDNA clone ip32c07
  2.363         CO586466             CO586466             DG2-130p9 DG2-brain Canis familiaris
  2.346         ENSCAFT00000022799   ENSCAFT00000022799   Fibronectin (FN) (Fragment)
  2.331         TCAP                 XM_858636            PREDICTED: Canis familiaris similar to Telethonin (Titin cap protein)
  2.322         LOC488991            XM_843985            PREDICTED: Canis familiaris similar to Protein FAM13C1
  2.309         PDZRN4               XM_543731            PREDICTED: Canis familiaris similar to PDZ domain containing RING finger protein 4 (Ligand of Numb-protein X 4)
  2.301         LOC607572            XM_844308            PREDICTED: Canis familiaris similar to ankyrin repeat domain 26
  2.286         PPP1R12A             XM_859971            PREDICTED: Canis familiaris similar to Protein phosphatase 1 regulatory subunit 12A (Myosin phosphatase targeting subunit 1)
  2.286         TC73854              TC73854              Unknown
  2.280         A_11_P0000024197     Unknown              TC47203

The pathways significantly implicated by the upregulated gene module (turquoise; [Fig 1 D](#pone.0150850.g001){ref-type="fig"}) include antigen processing and presentation, graft-versus-host disease, proteasome, and the lysosome. Specific genes from each upregulated pathway are detailed in [Table 3](#pone.0150850.t003){ref-type="table"}. The pathways significantly implicated by the downregulated gene module (blue; [Fig 1 E](#pone.0150850.g001){ref-type="fig"}) include dilated cardiomyopathy, focal adhesion, and arrhythmogenic right ventricular cardiomyopathy and are detailed in [Table 4](#pone.0150850.t004){ref-type="table"}. These identified pathways are consistent with pathways identified from prior expression arrays from MPS IIIb mouse brain \[[@pone.0150850.ref026], [@pone.0150850.ref030]\], MPS VII mouse brain \[[@pone.0150850.ref029]\] and liver \[[@pone.0150850.ref047]\].

10.1371/journal.pone.0150850.t003

###### Upregulated Canine Arterial IDUA^-/-^ Genes Sorted by Category.

Upregulated arterial genes in IDUA^-/-^ canines fall into categories associated with lysosomal function, proteasomal function, and the immune system (graft-versus-host disease and antigen processing).

![](pone.0150850.t003){#pone.0150850.t003g}

  Ontology Category                                                                                                                                                                                                       
  ---------------------------- ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ ----------------------------------------
  *\"LYSOSOMAL FUNCTION\"*                                                                                                                                                                                                
  [Gene Symbol]{.ul}           [Gene Name]{.ul}                                                                                                                                                                           [Entrez Gene ID]{.ul}
  ATP6V0C                      ATPase, H+ transporting, lysosomal 16kDa, V0 subunit c                                                                                                                                     479877
  ATP6V0B                      ATPase, H+ transporting, lysosomal 21kDa, V0 subunit b                                                                                                                                     482528
  ATP6V0D1                     ATPase, H+ transporting, lysosomal 38kDa, V0 subunit d1                                                                                                                                    479685
  ATP6V1H                      ATPase, H+ transporting, lysosomal 50/57kDa, V1 subunit H                                                                                                                                  486953
  ATP6V0A1                     ATPase, H+ transporting, lysosomal V0 subunit a1                                                                                                                                           607705
  ATP6AP1                      ATPase, H+ transporting, lysosomal accessory protein 1                                                                                                                                     610922
  CD63                         CD63 molecule                                                                                                                                                                              474391
  GM2A                         GM2 ganglioside activator                                                                                                                                                                  479324
  NAGA                         N-acetylgalactosaminidase, alpha                                                                                                                                                           481226
  GNPTAB                       N-acetylglucosamine-1-phosphate transferase, alpha and beta subunits                                                                                                                       475443
  NAGPA                        N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase                                                                                                                         490019
  NAGLU                        N-acetylglucosaminidase, alpha-                                                                                                                                                            490965
  ASAH1                        N-acylsphingosine amidohydrolase (acid ceramidase) 1                                                                                                                                       482897
  SGSH                         N-sulfoglucosamine sulfohydrolase                                                                                                                                                          403707
  NPC1                         Niemann-Pick disease, type C1                                                                                                                                                              403698
  TCIRG1                       T-cell, immune regulator 1, ATPase, H+ transporting, lysosomal V0 subunit A3                                                                                                               483691
  AP3B2                        adaptor-related protein complex 3, beta 2 subunit                                                                                                                                          479053
  AP3M1                        adaptor-related protein complex 3, mu 1 subunit                                                                                                                                            489052
  AP3S2                        adaptor-related protein complex 3, sigma 2 subunit                                                                                                                                         479042
  AP4B1                        adaptor-related protein complex 4, beta 1 subunit                                                                                                                                          483125
  ARSA                         arylsulfatase A                                                                                                                                                                            474457
  AGA                          aspartylglucosaminidase                                                                                                                                                                    475638
  CTSA                         cathepsin A                                                                                                                                                                                611146
  CTSB                         cathepsin B                                                                                                                                                                                486077
  CTSC                         cathepsin C                                                                                                                                                                                403458; 478608
  CTSD                         cathepsin D                                                                                                                                                                                483662
  CTSG                         cathepsin G                                                                                                                                                                                608543
  CTSH                         cathepsin H                                                                                                                                                                                479065
  CTSK                         cathepsin K                                                                                                                                                                                608843
  CTSL2                        cathepsin L2                                                                                                                                                                               403708
  CTSS                         cathepsin S                                                                                                                                                                                403400
  CTSZ                         cathepsin Z                                                                                                                                                                                611983
  CLTA                         clathrin, light chain (Lca)                                                                                                                                                                474765
  CTNS                         cystinosis, nephropathic                                                                                                                                                                   491220
  DNASE2                       deoxyribonuclease II, lysosomal                                                                                                                                                            476697
  GLB1                         galactosidase, beta 1                                                                                                                                                                      403873
  GBA                          glucosidase, beta; acid (includes glucosylceramidase)                                                                                                                                      612206
  GUSB                         glucuronidase, beta                                                                                                                                                                        403831
  GGA2                         golgi associated, gamma adaptin ear containing, ARF binding protein 2                                                                                                                      608555
  HGSNAT                       heparan-alpha-glucosaminide N-acetyltransferase                                                                                                                                            482833
  HEXA                         hexosaminidase A (alpha polypeptide)                                                                                                                                                       487633
  HEXB                         hexosaminidase B (beta polypeptide)                                                                                                                                                        478100
  LGMN                         legumain                                                                                                                                                                                   480232
  LIPA                         lipase A, lysosomal acid, cholesterol esterase                                                                                                                                             610650
  LAPTM5                       lysosomal multispanning membrane protein 5                                                                                                                                                 487324
  LAPTM4A                      lysosomal protein transmembrane 4 alpha                                                                                                                                                    475678
  LAMP1                        lysosomal-associated membrane protein 1                                                                                                                                                    476995
  LAMP2                        lysosomal-associated membrane protein 2                                                                                                                                                    481037
  M6PR                         mannose-6-phosphate receptor (cation dependent)                                                                                                                                            477700
  MAN2B1                       mannosidase, alpha, class 2B, member 1; similar to UPF0139 protein CGI-140                                                                                                                 476703; 484932
  MANBA                        mannosidase, beta A, lysosomal                                                                                                                                                             487883
  PPT1                         palmitoyl-protein thioesterase 1                                                                                                                                                           475316
  PPT2                         palmitoyl-protein thioesterase 2                                                                                                                                                           474856
  PSAP                         prosaposin                                                                                                                                                                                 479240
  SCARB2                       scavenger receptor class B, member 2                                                                                                                                                       478435
  NEU1                         sialidase 1 (lysosomal sialidase)                                                                                                                                                          481717
  AP1S2                        similar to Adapter-related protein complex 1 sigma 1B subunit (Sigma-adaptin 1B)                                                                                                           611468
  SLC11A1                      solute carrier family 11 (proton-coupled divalent metal ion transporters), member 1                                                                                                        478909
  SLC17A5                      solute carrier family 17 (anion/sugar transporter), member 5                                                                                                                               474969
  SORT1                        sortilin 1                                                                                                                                                                                 479915
  TPP1                         tripeptidyl peptidase I                                                                                                                                                                    485337
  *\"PROTEASOMAL FUNCTION\"*                                                                                                                                                                                              
  [Gene Symbol]{.ul}           [Gene Name]{.ul}                                                                                                                                                                           [Entrez Gene ID]{.ul}
  PSMC1                        proteasome (prosome, macropain) 26S subunit, ATPase, 1                                                                                                                                     478703
  PSMC2                        proteasome (prosome, macropain) 26S subunit, ATPase, 2                                                                                                                                     475896
  PSMC3                        proteasome (prosome, macropain) 26S subunit, ATPase, 3                                                                                                                                     475980
  PSMC5                        proteasome (prosome, macropain) 26S subunit, ATPase, 5                                                                                                                                     480478
  PSMD11                       proteasome (prosome, macropain) 26S subunit, non-ATPase, 11                                                                                                                                480610
  PSMD14                       proteasome (prosome, macropain) 26S subunit, non-ATPase, 14                                                                                                                                478765
  PSMD2                        proteasome (prosome, macropain) 26S subunit, non-ATPase, 2                                                                                                                                 478654
  PSMD3                        proteasome (prosome, macropain) 26S subunit, non-ATPase, 3                                                                                                                                 491018
  PSMD6                        proteasome (prosome, macropain) 26S subunit, non-ATPase, 6                                                                                                                                 484700
  PSMD8                        proteasome (prosome, macropain) 26S subunit, non-ATPase, 8                                                                                                                                 476470
  PSME1                        proteasome (prosome, macropain) activator subunit 1 (PA28 alpha)                                                                                                                           480256
  PSME2                        proteasome (prosome, macropain) activator subunit 2 (PA28 beta)                                                                                                                            480258
  PSME4                        proteasome (prosome, macropain) activator subunit 4                                                                                                                                        474594
  PSMA4                        proteasome (prosome, macropain) subunit, alpha type, 4                                                                                                                                     475132
  PSMA5                        proteasome (prosome, macropain) subunit, alpha type, 5                                                                                                                                     490123
  PSMA6                        proteasome (prosome, macropain) subunit, alpha type, 6                                                                                                                                     480290
  PSMA7                        proteasome (prosome, macropain) subunit, alpha type, 7                                                                                                                                     404305
  PSMB1                        proteasome (prosome, macropain) subunit, beta type, 1                                                                                                                                      475040
  PSMB10                       proteasome (prosome, macropain) subunit, beta type, 10                                                                                                                                     489749
  PSMB2                        proteasome (prosome, macropain) subunit, beta type, 2                                                                                                                                      475338
  PSMB3                        proteasome (prosome, macropain) subunit, beta type, 3                                                                                                                                      474987; 480537
  PSMB4                        proteasome (prosome, macropain) subunit, beta type, 4                                                                                                                                      475848
  PSMB5                        proteasome (prosome, macropain) subunit, beta type, 5                                                                                                                                      480246
  PSMB8                        proteasome (prosome, macropain) subunit, beta type, 8                                                                                                                                      474865
  PSMB9                        proteasome (prosome, macropain) subunit, beta type, 9                                                                                                                                      474867
  POMP                         proteasome maturation protein                                                                                                                                                              477325
  PSMA1                        similar to Proteasome subunit alpha type 1 (Proteasome component C2)                                                                                                                       476867; 608388; 610188; 612667; 613000
  PSMA3                        similar to Proteasome subunit alpha type 3 (Proteasome component C8)                                                                                                                       480338; 607261
  *\"GRAFT-VS-HOST\"*                                                                                                                                                                                                     
  [Gene Symbol]{.ul}           [Gene Name]{.ul}                                                                                                                                                                           [Entrez Gene ID]{.ul}
  CD80                         CD80 molecule                                                                                                                                                                              403765
  CD86                         CD86 molecule                                                                                                                                                                              403764
  DLA-12 / DLA-64              MHC class I DLA-12; MHC class I DLA-64                                                                                                                                                     474838; 541592
  DLA88                        MHC class I DLA-88                                                                                                                                                                         474836
  DLA-DRB1                     MHC class II DLA DRB1 beta chain                                                                                                                                                           474860
  DLA-DRA1                     MHC class II DR alpha chain                                                                                                                                                                481731
  DLA-79                       MHC class Ib                                                                                                                                                                               483594
  IL1A                         interleukin 1, alpha                                                                                                                                                                       403782
  IL1B                         interleukin 1, beta                                                                                                                                                                        403974
  IL2                          interleukin 2                                                                                                                                                                              403989
  IL6                          interleukin 6 (interferon, beta 2)                                                                                                                                                         403985
  HLA-DMA                      major histocompatibility complex, class II, DM alpha                                                                                                                                       481732
  HLA-DOB                      major histocompatibility complex, class II, DO beta                                                                                                                                        607786
  DLA-DQA1                     major histocompatibility complex, class II, DQ alpha 1                                                                                                                                     474861
  DLA-DQB1                     major histocompatibility complex, class II, DQ beta 1                                                                                                                                      474862
  *\"ANTIGEN PROCESSING\"*                                                                                                                                                                                                
  [Gene Symbol]{.ul}           [Gene Name]{.ul}                                                                                                                                                                           [Entrez Gene ID]{.ul}
  DLA-12 / DLA-64              MHC class I DLA-12; MHC class I DLA-64                                                                                                                                                     474838; 541592
  DLA88                        MHC class I DLA-88                                                                                                                                                                         474836
  DLA-DRB1                     MHC class II DLA DRB1 beta chain                                                                                                                                                           474860
  DLA-DRA1                     MHC class II DR alpha chain                                                                                                                                                                481731
  DLA-79                       MHC class Ib                                                                                                                                                                               483594
  TAPBP                        TAP binding protein (tapasin)                                                                                                                                                              481740
  B2M                          beta-2-microglobulin                                                                                                                                                                       478284
  CANX                         calnexin                                                                                                                                                                                   403908
  CTSB                         cathepsin B                                                                                                                                                                                486077
  CTSS                         cathepsin S                                                                                                                                                                                403400
  HSPA1L                       heat shock 70kDa protein 1-like                                                                                                                                                            474850
  HSP70                        heat shock protein 70                                                                                                                                                                      403612
  HSPA4                        heat shock protein Apg-2                                                                                                                                                                   474680
  KLRD1                        killer cell lectin-like receptor subfamily D, member 1                                                                                                                                     611360
  LGMN                         legumain                                                                                                                                                                                   480232
  HLA-DMA                      major histocompatibility complex, class II, DM alpha                                                                                                                                       481732
  HLA-DOB                      major histocompatibility complex, class II, DO beta                                                                                                                                        607786
  DLA-DQA1                     major histocompatibility complex, class II, DQ alpha 1                                                                                                                                     474861
  DLA-DQB1                     major histocompatibility complex, class II, DQ beta 1                                                                                                                                      474862
  NFYB                         nuclear transcription factor Y, beta                                                                                                                                                       475450
  NFYC                         nuclear transcription factor Y, gamma                                                                                                                                                      475312
  PSME1                        proteasome (prosome, macropain) activator subunit 1 (PA28 alpha)                                                                                                                           480256
  PSME2                        proteasome (prosome, macropain) activator subunit 2 (PA28 beta)                                                                                                                            480258
  RFXANK                       regulatory factor X-associated ankyrin-containing protein                                                                                                                                  476662
  LOC480726                    similar to 78 kDa glucose-regulated protein precursor (Endoplasmic reticulum lumenal Ca(2+) binding protein grp78)                                                                         480726
  LOC476669                    similar to Gamma-interferon inducible lysosomal thiol reductase precursor (Gamma-interferon-inducible protein IP-30)                                                                       476669
  LOC479329                    similar to HLA class II histocompatibility antigen, gamma chain (HLA-DR antigens associated invariant chain) (Ia antigen-associated invariant chain)                                       479329
  LOC607470                    similar to Heat shock protein HSP 90-alpha (HSP 86)                                                                                                                                        607470
  LOC490008                    similar to MHC class II transactivator                                                                                                                                                     490008
  HSPA8                        similar to heat shock 70kDa protein 8 isoform 2; heat shock 70kDa protein 8; similar to Heat shock cognate 71 kDa protein (Heat shock 70 kDa protein 8); similar to heat shock protein 8   479406; 607182; 608802
  LOC480438                    similar to heat shock protein 1, alpha                                                                                                                                                     480438
  LOC608885                    similar to heat shock protein 8                                                                                                                                                            608885

10.1371/journal.pone.0150850.t004

###### Down-regulated Canine Arterial IDUA^-/-^ Genes Sorted by Category.

Down-regulated arterial genes in IDUA^-/-^ dogs fall into categories associated with cytoskeletal proteins, cellular adhesion, and ion channels (termed arrhythmogenic right ventricular cardiomyopathy, focal adhesion, and dilated cardiomyopathy).
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  Ontology Category                                                                                                                              
  ------------------------------------------------------- -------------------------------------------------------------------------------------- --------------------------------
  *\"ARRHYTHMOGENIC RIGHT VENTRICULAR CARDIOMYOPATHY\"*                                                                                          
  [Systematic Name]{.ul}                                  [Gene Name]{.ul}                                                                       [Entrez Gene ID]{.ul}
  ACTB                                                    actin, beta                                                                            610787
  ACTN1                                                   actinin, alpha 1                                                                       480369
  ACTN2                                                   actinin, alpha 2                                                                       479191
  ACTN4                                                   actinin, alpha 4                                                                       484526
  LOC442937                                               beta-actin                                                                             442937
  CACNA1S                                                 calcium channel, voltage-dependent, L type, alpha 1S subunit                           490244
  CACNB1                                                  calcium channel, voltage-dependent, beta 1 subunit                                     491030
  CACNB2                                                  calcium channel, voltage-dependent, beta 2 subunit                                     487113
  CACNB4                                                  calcium channel, voltage-dependent, beta 4 subunit                                     609361
  CTNNA1                                                  catenin (cadherin-associated protein), alpha 2                                         483088
  CTNNA3                                                  catenin (cadherin-associated protein), alpha 3                                         489008
  DES                                                     desmin                                                                                 497091
  DSC2                                                    desmocollin 2                                                                          403860
  DMD                                                     dystrophin (muscular dystrophy, Duchenne and Becker types)                             606758
  GJA1                                                    gap junction protein, alpha 1, 43kDa                                                   403418
  ITGA5                                                   integrin, alpha 5 (fibronectin receptor, alpha polypeptide)                            486493
  ITGA6                                                   integrin, alpha 6                                                                      478800
  ITGA8                                                   integrin, alpha 8                                                                      487119
  ITGA9                                                   integrin, alpha 9                                                                      477021
  ITGB4                                                   integrin, beta 4                                                                       483318
  ITGB8                                                   integrin, beta 8                                                                       475253
  RYR2                                                    ryanodine receptor 2 (cardiac)                                                         403615
  SGCG                                                    sarcoglycan, gamma (35kDa dystrophin-associated glycoprotein)                          486043
  LOC492249                                               similar to Emerin                                                                      492249
  *\"DILATED CARDIOMYOPATHY\"*                                                                                                                   
  [Systematic Name]{.ul}                                  [Gene Name]{.ul}                                                                       [Entrez Gene ID]{.ul}
  GNAS                                                    GNAS complex locus                                                                     403943
  ACTB                                                    actin, beta                                                                            610787
  ADCY2                                                   adenylate cyclase 2 (brain)                                                            478624
  ADCY5                                                   adenylate cyclase 5                                                                    403859
  ADCY9                                                   adenylate cyclase 9                                                                    490031
  LOC442937                                               beta-actin                                                                             442937
  CACNA1S                                                 calcium channel, voltage-dependent, L type, alpha 1S subunit                           490244
  CACNB1                                                  calcium channel, voltage-dependent, beta 1 subunit                                     491030
  CACNB2                                                  calcium channel, voltage-dependent, beta 2 subunit                                     487113
  CACNB4                                                  calcium channel, voltage-dependent, beta 4 subunit                                     609361
  DES                                                     desmin                                                                                 497091
  DMD                                                     dystrophin (muscular dystrophy, Duchenne and Becker types)                             606758
  ITGA5                                                   integrin, alpha 5 (fibronectin receptor, alpha polypeptide)                            486493
  ITGA6                                                   integrin, alpha 6                                                                      478800
  ITGA8                                                   integrin, alpha 8                                                                      487119
  ITGA9                                                   integrin, alpha 9                                                                      477021
  ITGB4                                                   integrin, beta 4                                                                       483318
  ITGB8                                                   integrin, beta 8                                                                       475253
  PLN                                                     phospholamban                                                                          414755
  RYR2                                                    ryanodine receptor 2 (cardiac)                                                         403615
  SGCG                                                    sarcoglycan, gamma (35kDa dystrophin-associated glycoprotein)                          486043
  LOC492249                                               similar to Emerin                                                                      492249
  TTN                                                     titin                                                                                  478819
  TPM3                                                    tropomyosin 3; tropomyosin 1 (alpha); similar to tropomyosin 1 alpha chain isoform 4   478332; 480137; 484695; 491970
  TNF                                                     tumor necrosis factor (TNF superfamily, member 2)                                      403922
  *\"FOCAL ADHESION\"*                                                                                                                           
  [Systematic Name]{.ul}                                  [Gene Name]{.ul}                                                                       [Entrez Gene ID]{.ul}
  RAP1A                                                   RAP1A, member of RAS oncogene family                                                   483225
  RAPGEF1                                                 Rap guanine nucleotide exchange factor (GEF) 1                                         491286
  ARHGAP5                                                 Rho GTPase activating protein 5                                                        490642
  ROCK1                                                   Rho-associated, coiled-coil containing protein kinase 1                                480181
  ACTB                                                    actin, beta                                                                            610787
  ACTN1                                                   actinin, alpha 1                                                                       480369
  ACTN2                                                   actinin, alpha 2                                                                       479191
  ACTN4                                                   actinin, alpha 4                                                                       484526
  LOC442937                                               beta-actin                                                                             442937
  CAV1                                                    caveolin 1, caveolae protein, 22kDa                                                    403980
  CAV2                                                    caveolin 2                                                                             403611; 475294
  COL1A1                                                  collagen, type I, alpha 1                                                              403651
  COL1A2                                                  collagen, type I, alpha 2                                                              403824
  COL2A1                                                  collagen, type II, alpha 1                                                             403826
  COL4A1                                                  collagen, type IV, alpha 1                                                             403496
  COL5A1                                                  collagen, type V, alpha 1                                                              480684
  COL6A3                                                  collagen, type VI, alpha 3                                                             403582
  FLNC                                                    filamin C, gamma (actin binding protein 280)                                           482266
  ITGA5                                                   integrin, alpha 5 (fibronectin receptor, alpha polypeptide)                            486493
  ITGA6                                                   integrin, alpha 6                                                                      478800
  ITGA8                                                   integrin, alpha 8                                                                      487119
  ITGA9                                                   integrin, alpha 9                                                                      477021
  ITGB4                                                   integrin, beta 4                                                                       483318
  ITGB8                                                   integrin, beta 8                                                                       475253
  LAMA3                                                   laminin, alpha 3                                                                       480173
  LAMB2                                                   laminin, beta 2 (laminin S)                                                            476626
  MET                                                     met proto-oncogene (hepatocyte growth factor receptor)                                 403438
  MAPK8                                                   mitogen-activated protein kinase 8                                                     477746
  MYLK                                                    myosin light chain kinase                                                              488012
  MYLK2                                                   myosin light chain kinase 2                                                            477187
  PAK4                                                    p21 protein (Cdc42/Rac)-activated kinase 4                                             484513
  PIK3CA                                                  phosphoinositide-3-kinase, catalytic, alpha polypeptide                                488084
  PIK3R2                                                  phosphoinositide-3-kinase, regulatory subunit 2 (beta)                                 609956
  PGF                                                     placental growth factor                                                                611916
  PDGFD                                                   platelet derived growth factor D                                                       479460
  PDGFRB                                                  platelet-derived growth factor receptor, beta polypeptide                              442985
  PPP1CB                                                  protein phosphatase 1, catalytic subunit, beta isoform                                 403558
  PPP1CC                                                  protein phosphatase 1, catalytic subunit, gamma isoform                                403557
  PPP1R12A                                                protein phosphatase 1, regulatory (inhibitor) subunit 12A                              475411
  RHOA                                                    ras homolog gene family, member A                                                      403954
  LOC479252                                               similar to Vinculin (Metavinculin)                                                     479252
  LOC479790                                               similar to mitogen activated protein kinase 3                                          479790
  TLN1                                                    talin 1                                                                                474759
  TNC                                                     tenascin C                                                                             481689
  AKT2                                                    v-akt murine thymoma viral oncogene homolog 2                                          449021
  CRKL                                                    v-crk sarcoma virus CT10 oncogene homolog (avian)-like                                 608125

Next, gene networks were constructed, utilizing two methods to identify any potential interactions between genes with perturbed expression. The first was *de novo* using WGCNA, and the second utilized GeneMania. Signed networks were constructed in WGCNA using an adjacency function that incorporates gene correlation and connectivity across the dataset. GeneMania networks were constructed based on known interactions such as co-expression, shared protein domains, signaling pathways, physical interactions, genetic interactions, and co-localization. The results of the GeneMania-generated network analysis are shown in [Fig 2](#pone.0150850.g002){ref-type="fig"}, with correlated upregulated genes in the MPS I dogs in [Fig 2A](#pone.0150850.g002){ref-type="fig"}: notable genes exceeding 2-fold expression change in the upregulated network include lysosomal proteases (CTSB, CTSK, CTSS, LGMN); RRAGD, a GTPase involved with lysosomal energy sensing; immunity-related genes such as CD86, a macrophage-related signaling protein; BPI, a protein that binds bacterial lipopolysaccharide; and CLU, a marker previously identified in inflammatory processes and atherosclerosis. [Fig 2B](#pone.0150850.g002){ref-type="fig"} shows the correlated downregulated (reduced 2-fold) gene network in the MPS I dogs. Many of the downregulated genes are smooth muscle cytoskeletal elements, including TCAP (titin-cap), TPN1 (tropomyosin), DMD (dystrophin), SMTN (smoothelin), TAGLN (transgelin), MYH11 (smooth muscle myosin heavy chain 11), and CNN1 (smooth muscle calponin 1).

![Up- and Downregulated Gene Networks in IDUA^-/-^ Canine Arteries.\
Gene networks formed using GeneMania using the top related genes and at most 20 attributes. Interactions observed include co-expression, co-localization, genetic interactions, pathway, and physical interactions. A. Network of the upregulated genes. Notable genes in the upregulated network include lysosomal proteases (CTSB, CTSK, CTSS, LGMN); RRAGD, a GTPase involved in lysosomal energy sensing; immunity-related genes such as CD86 and BPI; and clusterin, a protein associated with atherosclerotic cardiovascular disease. B. Network of the downregulated genes. The notable genes in the downregulated network are primarily smooth muscle cytoskeletal elements (CNN1, DMD, MYH11, SMTH, TAGLN, TCAP, and TPN1).](pone.0150850.g002){#pone.0150850.g002}

We further examined the expression pattern of clusterin, which was present in the upregulated gene network and the most significantly overexpressed gene ([S3 Fig](#pone.0150850.s004){ref-type="supplementary-material"}). The clusterin overexpression especially interested us, as it has been shown to be is involved in morphologic transformation of vascular smooth muscle cells \[[@pone.0150850.ref048]\] and present in human atherosclerotic plaques \[[@pone.0150850.ref049]\]. The MPS I dog aortas contained multiple eccentric plaques that intruded into the lumen, consistent with previous reports of vascular pathology in the model \[[@pone.0150850.ref023]\]. Importantly, we confirmed that clusterin protein is overexpressed in MPS I ascending (1.3-fold) and descending aortas (1.62-fold) compared to unaffected heterozygous dogs ([Fig 3](#pone.0150850.g003){ref-type="fig"}). The clusterin protein is localized primarily within the plaques of the MPS I aortas; little to no clusterin signal was seen in the control aortas ([Fig 4](#pone.0150850.g004){ref-type="fig"}). These results provide protein-level confirmation of clusterin gene overexpression within MPS I arterial vasculature. Additionally, Toll-like receptor 4 (TLR4) protein overexpression and increased phosphorylated STAT1 protein were seen only in canine MPS I arteries ([S4 Fig](#pone.0150850.s005){ref-type="supplementary-material"}).

![Western Blot of Clusterin and Smooth Muscle Actin in Canine Aortas.\
Clusterin is predicted to appear as a thicker band between 35--39 kDa owing to differential glycosylation. Alpha smooth muscle actin is predicted to appear at approximately 42 kDa. 20 μg of total protein was loaded in each lane. The upper set is from ascending aorta and the lower set is from descending aorta. Normalized mean clusterin band intensities from descending and ascending aortas are 1.62 and 1.3 fold greater in MPS I animals compared to unaffected animals.](pone.0150850.g003){#pone.0150850.g003}

![Canine Arterial Clusterin Immunohistochemistry.\
The MPS I aorta (right panel) has an overall increase in clusterin signal compared to unaffected aorta (left panel), and also contains an eccentric plaque (arrowhead) that stains strongly for clusterin.](pone.0150850.g004){#pone.0150850.g004}

Next, we assessed whether adult C57/Bl6 *Idua*^-/-^ mice had similar cardiovascular findings to the IDUA^-/-^ dogs, especially with regards to aortic histopathology. The mice had grossly evident hypertrophic cardiomyopathy compared to *Idua*^*+/-*^ control mice, which is consistent with other assessments of cardiovascular phenotype \[[@pone.0150850.ref023]\]. While not as prominent as the canine MPS I model, the *Idua*^-/-^ mice also demonstrated eccentric, sclerotic plaques and thickened proximal aortas compared to control mice. These plaques were visible only near the sinuses of Valsalva, a distribution different from the canine plaques, which were present throughout the ascending and descending aorta. Clusterin protein was absent in the control mice ([Fig 5A](#pone.0150850.g005){ref-type="fig"}), and prominently visible in the aortic plaques of the *Idua*^-/-^ mice ([Fig 5B](#pone.0150850.g005){ref-type="fig"}). The full clusterin and smooth muscle actin blots can be viewed in [S5 Fig](#pone.0150850.s006){ref-type="supplementary-material"}.

![Murine Aortic Clusterin Immunohistochemistry.\
Taken at the level of the sinuses of Valsalva, the MPS I mouse aorta (right panel) is thicker than the wild-type mouse (left panel) and also contains an eccentric plaque (arrowhead) staining strongly for clusterin.](pone.0150850.g005){#pone.0150850.g005}

Discussion {#sec016}
==========

We performed microarray analyses comparing arterial gene expression of untreated MPS I canines to unaffected heterozygous canines to gain insights into the gene perturbations caused by α-L-iduronidase deficiency and subsequent arterial glycosaminoglycan storage. Our study represents a comprehensive assessment of gene expression in the vasculature of any MPS model system, and identified upregulation of genes related to lysosomes, proteasomes, macrophages, and innate immunity. We also identified downregulation of cytoskeletal genes and calcium channel subunits. Our findings are consistent with results of gene expression studies from non-vascular tissues in differing MPS subtypes. This indicates the possibility that common mechanisms may be responsible for pathogenesis of MPS disease in multiple organ systems. We also identified evidence linking the innate immune system to pathogenesis of MPS I cardiovascular disease, as well as a biomarker for potentially following disease progression and treatment efficacy.

Overexpression of lysosomal hydrolases and housekeeping genes is consistent with the hypothesis that accumulation of primary substrate in lysosomal storage disorders results in a "traffic jam" with secondarily impaired degradation of other lysosomal substrates, and subsequent efforts by the cell to alleviate the secondary storage \[[@pone.0150850.ref050]\]. Our findings of cathepsin protease overexpression are consistent with aortic cathepsin B, D, L, and S overexpression from the mouse and canine models of MPS I and VII \[[@pone.0150850.ref031], [@pone.0150850.ref033], [@pone.0150850.ref034]\]. In addition, overexpression of lysosomal membrane proteins and enzymes has been observed in murine MPS VII liver \[[@pone.0150850.ref047]\] and brain \[[@pone.0150850.ref029]\]. An additional effect of the lysosomal traffic jam is impairment in organelle and protein degradation via a lysosome-dependent pathway known as autophagy \[[@pone.0150850.ref051]\]. Since the ubiquitin-proteasome system (UPS) is another prominent mechanism for recycling of accumulated proteins, the observed upregulation of proteasomal genes may indicate diversion of protein catabolism towards the UPS.

Downregulation of cellular adhesion and cytoskeletal genes (labeled as "Dilated Cardiomyopathy," "Focal Adhesion," and "Arrhythmogenic Right Ventricular Cardiomyopathy\" in our study) has also been seen in MPS IIIb mouse brains \[[@pone.0150850.ref030]\]. These results support data suggesting that excess HS oligosaccharides impair function of cellular adhesion molecules and disrupt normal polarization and orientation of cultured MPSIIIB mouse astrocytes or neural stem cells \[[@pone.0150850.ref052]\].

The generalized upregulation of macrophage and immunity-related genes observed in the MPS I arteries indicate that inflammation may play a prominent role in the pathogenesis of MPS I cardiovascular disease. This immune-associated gene overexpression was also seen in several expression studies in MPS IIIb mice brains \[[@pone.0150850.ref026], [@pone.0150850.ref030]\] and is consistent with neuroinflammation observed in murine MPS IIIb and other neuropathic lysosomal storage disorders, including Sandhoff Disease and MPS I \[[@pone.0150850.ref053], [@pone.0150850.ref054]\]. While exploring potential etiologies of MPS I cardiovascular disease, significant overexpression of the Toll-like receptor 4 gene, in addition to numerous cathepsin proteases and matrix metalloproteinases was observed \[[@pone.0150850.ref034]\]. When MPS VII / cathepsin S and MPS VII / MMP-12 double knockout mice continued to develop arterial elastin degradation and aortic root dilatation, it was concluded that other proteases or inflammatory signals transduced by TLR4 activation could be responsible for the MPS VII cardiovascular phenotype \[[@pone.0150850.ref031]\].

TLR4 is a transmembrane protein that belongs to a family of proteins known as Pattern Recognition Receptors (PRRs). PRRs are expressed by cells of the innate immune system, bind foreign molecules that are typically associated with infections (pathogen-associated molecular patterns or PAMPs) or molecules released by damaged cells (damage-associated molecular patterns or DAMPs), and activate an immune response \[[@pone.0150850.ref055]\]. Lipopolysaccharide, the canonical PAMP for bacteria, activates TLR4 signaling. Acting via the MyD88 adaptor and STAT1 protein phosphorylation, activated TLR4 results in nuclear translocation of the transcription factor NF-κB and subsequent mRNA expression of proinflammatory cytokines.

Following the discovery that heparan sulfate, but neither chondroitin sulfate nor heparin, activates TLR4 signaling in dendritic cells and macrophages, evidence has been accumulating that heparan sulfate may play a role in the pathogenesis of MPS neurologic and orthopedic disease via TLR4-induced inflammation \[[@pone.0150850.ref056]--[@pone.0150850.ref058]\]. Wild-type mouse microglia respond in a dose-dependent fashion to HS-oligosaccharides isolated from MPS IIIB patients with overexpression of macrophage inflammatory protein 1α (*Mip1a* or *Ccl3*) and interleukin 1β mRNAs. There was significantly reduced cytokine mRNA expression when the same HS-oligosaccharides were administered to *Tlr4*^-/-^ or *MyD88*^-/-^ mouse microglia. MPS IIIb (*Naglu*^-/-^) mouse brains overexpress *Mip1a* mRNA as early as postnatal day 10 with concomitant microglial activation and neuroinflammation. *Naglu* / *Tlr4* and *Naglu* / *MyD88* double knockout mice did not overexpress *Mip1a* and demonstrated delayed neuroinflammation \[[@pone.0150850.ref033]\]. Similar neuroinflammatory findings have been reported in MPS IIIa, IIIb, and IIIc mice, all of which accumulate HS \[[@pone.0150850.ref028]\].

Our results suggest that HS--TLR4 mediated, monocyte/macrophage-induced inflammation contributes to the pathogenesis of cardiovascular disease in MPS I. Among the genes with highest overexpression in MPS I arteries was CD86 which, in conjunction with another overexpressed gene CD80, encode proteins found on the cell surface of activated monocytes. Other immunity-related genes with observed overexpression were members of the major histocompatibility complex II families, which are involved in antigen presentation and are found primarily on monocytes, macrophages, and dendritic cells. In addition, overexpression of the inflammatory cytokines interleukin-1α, interleukin-1β, interleukin 2, and interleukin 6 were observed. We also identified MPS I arterial overexpression of TLR4 protein and evidence of its activation via increased levels of phosphorylated STAT1.

Heparan sulfate-mediated inflammation cannot be the sole etiology of MPS cardiovascular disease pathogenesis. Patients who have MPS type VI store only DS GAG but often develop mitral or aortic valve dysfunction severe enough to necessitate surgical valve replacement, and also demonstrate coronary artery intimal thickening with arterial stiffness \[[@pone.0150850.ref002], [@pone.0150850.ref019],[@pone.0150850.ref059]\]. Although the effects of DS GAG on TLR4 in MPS have not been directly investigated, there are studies that indicate it may also serve as a PAMP for TLR4 and promote inflammation like HS GAGs \[[@pone.0150850.ref060], [@pone.0150850.ref061]\]. Post-mortem studies of several MPS IVa patients, who store neither HS nor DS but accumulate keratan and chondroitin sulfate GAGs, have also demonstrated coronary sclerosis or aortic intimal thickening with macrophage infiltration and elastin fibril disruption \[[@pone.0150850.ref062], [@pone.0150850.ref063]\].

As our primary focus was canine MPS I arterial disease, mRNA and protein quantification of murine aorta clusterin or pSTAT1 were not performed. Despite this limitation, our study provides evidence from both canine and murine models confirming clusterin protein overexpression within MPS I arterial lesions. We believe that clusterin may have utility as an *in vivo* biomarker of MPS I cardiovascular disease for several reasons. First, overexpression of clusterin has been observed in many inflammatory conditions, including human atheromatous atherosclerosis, where it is observed only in vascular smooth muscle cells and stroma of atheromas and not in normal aorta \[[@pone.0150850.ref064], [@pone.0150850.ref065]\]. Second, while the effects of clusterin overexpression on human cardiovascular disease are unclear and may be pro-atherosclerotic \[[@pone.0150850.ref066]\] or protective \[[@pone.0150850.ref067], [@pone.0150850.ref068]\], clusterin serum levels correlate with severity of coronary artery stenosis and are highest during active myocardial infarction \[[@pone.0150850.ref069], [@pone.0150850.ref070]\]. Although lipid-mediated atheroma formation and atherosclerosis appear to proceed via pathways distinct from what occurs in MPS I, the roles of macrophages, inflammation, and Toll-like receptors in promoting atherosclerosis are well known \[[@pone.0150850.ref071]\]. Further studies are required to determine if circulating clusterin levels are indeed elevated in human MPS I patients, and if those levels correlate with severity of their cardiovascular disease.

Because GAGs are naturally present in healthy aortas \[[@pone.0150850.ref072]\], it will be important in the design of MPS cardiovascular disease therapeutics to determine if the arterial inflammation is caused solely by a quantitative increase of GAGs, or if the GAGs stored in MPS possess additional qualitative pro-inflammatory effects. The presence of storage-induced inflammation within MPS I canine arteries suggests several possible therapeutic strategies. Modified IDUA enzymes are being developed that have the potential to permeate deeper into the vascular parenchyma to alleviate GAG storage. An alternative strategy is the development of small molecule therapies that diffuse into arterial parenchyma and block the inflammatory response leading to MPS cardiovascular disease via inhibition of TLR4 signaling or pro-inflammatory cytokines. In fact, preclinical studies have been performed to investigate each of these modalities \[[@pone.0150850.ref073]--[@pone.0150850.ref076]\], and human clinical trials are in progress (European Union Clinical Trials Register \# 2014-000350-11). Clusterin represents a promising biomarker to monitor efficacy of these therapeutic candidates in both preclinical and clinical studies for MPS I cardiovascular disease. The murine MPS I model system can be utilized to test efficacy of potential therapeutics targeted towards MPS cardiovascular disease.

Supporting Information {#sec017}
======================

###### Protocol for murine *Idua* genotyping.

This protocol was utilized for identifying the *Idua* genotype of the mice utilized in this study.

(PDF)

###### 

Click here for additional data file.

###### Dendrogram and trait heatmap of the IDUA^-/-^ and control canine aorta samples.

The control samples cluster together and the IDUA^-/-^ canine aorta samples cluster together. The same results are found if data from each tissue type is analyzed separately for up- and down-regulated genes, respectively.

(TIF)

###### 

Click here for additional data file.

###### Module trait-relationship table.

Modules are designated on the left and the trait relationship is on the bottom (A for ascending aorta, C for carotid artery, and D for descending aorta). The table shows the correlation (top value) and the significance (bottom value) for each module-trait relationship. The turquoise and blue modules show the highest significance and thus were used for further analysis.

(TIF)

###### 

Click here for additional data file.

###### Identity of top perturbed genes within modules.

In the turquoise and blue modules, further assessment identified the top genes based on fold- change and p-value using Student's t-test. A. Volcano plot of the--log~10~ of the p-value vs. log~2~ of fold change. B. Top up- and down-regulated genes in the module are represented in a bar graph with a log~2~ scale.

(TIF)

###### 

Click here for additional data file.

###### TLR4 and pSTAT1 immunohistochemistry.

Immunohistochemistry for demonstrates overexpression of TLR4 in canine MPS I aorta, but not in unaffected canine aorta. The presence of increased pSTAT1 in canine MPS I aorta compared to unaffected canine aorta is evidence for TLR4 activation.

(TIF)

###### 

Click here for additional data file.

###### Clusterin Western blotting.

Scan of raw radiograph (Thermo Scientific CL-XPosure Film, ThermoFisher Scientific, Waltham, MA) exposure depicting enhanced chemiluminescence detection of canine aorta WB probed with anti-human clusterin alpha chain (EMD Millipore, Billerica, MA) and with anti-human smooth muscle alpha-actin (Dako North America, Inc., Carpinteria, CA). Hand written annotations refer to specific animal identifiers marking the lanes. Samples from descending or ascending aorta are grouped together and labeled as IDUA^+/-^ (carrier) or IDUA^-/-^ (MPS I). Handwritten markings indicate size and position of color coded protein ladder size markers (PageRuler Prestained Protein Ladder, Life Technologies, Grand Island, NY) traced by overlaying the film onto the transfer membrane. Clusterin is predicted to appear as a band between 35--39 kDa owing to differential glycosylation, while alpha smooth muscle actin is predicted to appear at approximately 42 kDa.

(TIF)

###### 

Click here for additional data file.

###### Significantly upregulated genes within IDUA^-/-^ canine aorta.

The full list of mRNA probes showing significant (p-value ≤ 0.05) and greater than 2-fold level of upregulation in IDUA^-/-^ canine arteries, compared to controls. Note that some genes are represented more than once due to existence of multiple mRNA probes per gene.

(XLSX)

###### 

Click here for additional data file.

###### Significantly down-regulated genes within IDUA^-/-^ canine aorta.

The full list of mRNA probes showing significant (p-value ≤ 0.05) and greater than 2-fold level of down-regulation in IDUA^-/-^ canine arteries, compared to controls. Again, some genes are represented more than once due to existence of multiple mRNA probes per gene.

(XLSX)

###### 

Click here for additional data file.
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